Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dyne Therapeutics, Inc.(DYN) | 4,951,303 | 4,951,303 | 0 | 44,364 | 65,852 | 32.36% | +21,489 |
| Werewolf Therapeutics, Inc. | 4,284,172 | 4,284,172 | 0 | 9,168 | 16,537 | 8.13% | +7,369 |
| Harpoon Therapeutics, Inc. | 0 | 313,136 | +313,136 | 0 | 3,560 | 1.75% | +3,560 |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | 29,990 | 29,990 | 14.74% | 0 |
| Adaptimmune Therapeutics plc | 6,287,101 | 5,555,461 | -731,640 | 4,904 | 4,405 | 2.16% | -498 |
| Harpoon Therapeutics, Inc. | 313,136 | 0 | -313,136 | 1,262 | 0 | — | -1,262 |
| Entrada Therapeutics, Inc. | 4,425,784 | 4,425,784 | 0 | 69,927 | 66,785 | 32.82% | -3,142 |
| Repare Therapeutics, Inc. | 2,242,636 | 2,242,636 | 0 | 27,091 | 16,371 | 8.04% | -10,720 |